Consainsights logo
Reports > Life Sciences > Apheresis Market Report

Apheresis Market Size, Share, Industry Trends and Forecast to 2033

This report provides comprehensive insights into the apheresis market from 2023 to 2033, including industry trends, market size, segmentation, and forecasts. It aims to equip stakeholders with the necessary data for informed decision-making.

Metric Value
Study Period 2023 - 2033
2023 Market Size $2.50 Billion
CAGR (2023-2033) 6.8%
2033 Market Size $4.91 Billion
Top Companies Fresenius Kabi, Terumo BCT, Haemonetics Corporation, Cerus Corporation
Last Modified Date 15 Nov 2024

Apheresis Market Report (2023 - 2033)

Apheresis Market Overview

The apheresis industry is distinguished by a dynamic competitive landscape shaped by key players investing in R&D for advanced apheresis devices. The trend toward precision medicine and personalized healthcare drives innovations in treatment protocols. Regulatory challenges regarding product approvals and safety standards remain a concern, but ongoing collaborations among healthcare providers, policymakers, and industry leaders aim to enhance apheresis procedures and patient accessibility. Overall, the industry reflects a robust potential for growth, provided the stakeholders effectively navigate market challenges and capitalize on emerging opportunities.

What is the Market Size & CAGR of Apheresis market in 2023?

In 2023, the global apheresis market is estimated to be valued at approximately $3.09 billion. The market is projected to grow at a compound annual growth rate (CAGR) of 8.12% from 2023 to 2033. This growth is fueled by factors such as the increasing prevalence of blood disorders, technological advancements, and the growing number of apheresis procedures performed globally. By 2033, the market is expected to reach approximately $6.28 billion, highlighting the market's potential for expansion in the next decade.

Apheresis Industry Analysis

The apheresis industry is distinguished by a dynamic competitive landscape shaped by key players investing in R&D for advanced apheresis devices. The trend toward precision medicine and personalized healthcare drives innovations in treatment protocols. Regulatory challenges regarding product approvals and safety standards remain a concern, but ongoing collaborations among healthcare providers, policymakers, and industry leaders aim to enhance apheresis procedures and patient accessibility. Overall, the industry reflects a robust potential for growth, provided the stakeholders effectively navigate market challenges and capitalize on emerging opportunities.

Apheresis Market Segmentation and Scope

The apheresis market can be segmented based on product types, applications, and end-users. Key product segments include apheresis devices, blood collection sets, and consumables. The various applications encompass therapeutic apheresis, donor apheresis, and others, focusing on disease management and research purposes. End-users include hospitals, blood banks, and research centers. Each segment plays a significant role in contributing to market growth, with therapeutic apheresis being the dominant segment accounting for the majority of the market share due to an increasing number of chronic diseases requiring treatment.

Request a custom research report for industry.

Apheresis Market Analysis Report by Region

Europe Apheresis Market Report:

The European apheresis market was valued at $0.70 billion in 2023, projected to expand to $1.38 billion by 2033. The region's strong regulatory framework, coupled with rising healthcare investments and increasing patient access to apheresis treatments, positions Europe as a significant player in the global market.

Asia Pacific Apheresis Market Report:

The Asia Pacific apheresis market is valued at $0.49 billion in 2023 and is expected to grow to $0.97 billion by 2033. Rapid urbanization, increasing healthcare expenditures, and rising awareness about therapeutic apheresis procedures comprise major growth drivers in this region. Countries such as China and India showcase significant potential for market expansion due to their large populations and increasing prevalence of blood diseases.

North America Apheresis Market Report:

North America remains the largest market for apheresis, with a value of $0.82 billion in 2023, anticipated to grow to $1.61 billion by 2033. The dominance is influenced by high healthcare spending, advanced medical technologies, and the widespread adoption of therapeutic apheresis processes in hospitals and clinics. The USA leads the market due to its robust healthcare system and focus on innovation.

South America Apheresis Market Report:

In South America, the market is valued at $0.13 billion in 2023 and is expected to reach $0.26 billion by 2033. The growth in this region is propelled by improvements in healthcare infrastructure and better access to advanced medical technologies, along with an increasing emphasis on blood donation campaigns to support larger apheresis programs.

Middle East & Africa Apheresis Market Report:

The Middle East and Africa apheresis market stood at $0.35 billion in 2023 and is expected to reach $0.69 billion by 2033. Growth in this region is driven by an increasing number of healthcare facilities and growing awareness about therapeutic blood collection methods, along with initiatives by governments to improve the healthcare landscape.

Request a custom research report for industry.

Apheresis Market Analysis By Product

Global Apheresis Market, By Product Market Analysis (2023 - 2033)

In the product segment, blood collection sets dominate the market, valued at $1.61 billion in 2023, with a projection to reach $3.16 billion by 2033, accounting for around 64.22% market share. Apheresis devices will see significant growth from $0.52 billion in 2023 to $1.03 billion in 2033, holding 20.94% share, while consumables are expected to double to $0.73 billion by 2033.

Apheresis Market Analysis By Application

Global Apheresis Market, By Application Market Analysis (2023 - 2033)

Therapeutic apheresis is the largest segment, estimated at $2.17 billion in 2023 and projected to grow to $4.27 billion by 2033, maintaining a dominant share of 86.96%. Donor apheresis accounts for a smaller share, forecasted to rise from $0.33 billion to $0.64 billion over the same period.

Apheresis Market Analysis By End User

Global Apheresis Market, By End-User Market Analysis (2023 - 2033)

Hospitals lead in end-user applications, currently valued at $1.61 billion in 2023 and expected to hit $3.16 billion by 2033. Blood banks and research centers, while smaller markets at $0.52 billion and $0.37 billion respectively in 2023, will also show promising growth.

Apheresis Market Analysis By Region

Global Apheresis Market, By Region Market Analysis (2023 - 2033)

The regional analysis confirms North America as the largest market with ongoing innovations, followed by Europe and Asia-Pacific as rapidly growing regions due to improvements in healthcare and rising disease prevalence, while South America and the Middle East/Africa present emerging opportunities for market penetration.

Apheresis Market Trends and Future Forecast

As we look forward to 2033, the apheresis market is expected to be shaped by several trends, including growing demand for individualized treatment options, technological advancements in devices, and improved patient outcomes. The increasing prevalence of autoimmune diseases and chronic conditions will further drive the growth of therapeutic apheresis. However, challenges including regulatory hurdles and device maintenance issues may impact overall market growth. Developing regions will continue to explore potential growth avenues, driven by improved healthcare policies and investment in medical technology.

Request a custom research report for industry.

Global Market Leaders and Top Companies in Apheresis Industry

Fresenius Kabi:

A leading provider of apheresis products and services, Fresenius Kabi focuses on innovative solutions for blood and cell therapy.

Terumo BCT:

Terumo specializes in blood collection and processing systems, with a strong emphasis on apheresis technologies to enhance patient care.

Haemonetics Corporation:

Identified as a global leader in blood management solutions, their advanced apheresis devices improve donor safety and therapeutic outcomes.

Cerus Corporation:

Cerus is known for its innovative INTERCEPT Blood System, enhancing blood safety and optimizing apheresis procedures across the globe.

We're grateful to work with incredible clients.

Datasite
Agilent
Asten Johnson
Bio-Rad
Carl Zeiss
Dywidag
Illumina
LEK Consulting
Shell

Related Industries

    FAQs